COVID‐19 in vaccinated versus unvaccinated hematologic malignancy patients. Issue 6 (16th August 2022)

• Record Type: Journal Article
• Authors: DeVoe, Catherine; Pandey, Shraddha; Shariff, Dayana; Arora, Shagun; Henrich, Timothy J.; Yokoe, Deborah S.; Langelier, Charles R.; Servellita, Venice; Chiu, Charles; Miller, Steve; Babik, Jennifer M.; Chin‐Hong, Peter; Fung, Monica
• Is Part Of: Transplant infectious disease. Volume 24:Issue 6(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-08-16
• Subjects: breakthrough infection -- COVID‐19 -- hematologic malignancy; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.13835
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: The effect of vaccination on severity of subsequent COVID‐19 in patients with hematologic malignancies (HMs) is unknown. In this single‐center retrospective cohort study, we found no difference in severity of COVID‐19 disease in vaccinated ( n = 16) versus unvaccinated ( n = 54) HM patients using an adjusted multiple logistic regression model. Recent anti‐B‐cell therapy was associated with more severe illness. Abstract :